Editorial Board
  • Edward Chu

    Albert Einstein College of Medicine, USA

    Interests: cancer pharmacology and drug development

  • Enrico Mini

    University of Florence Florence, ITALY

    Interests: the mechanisms of tumor drug resistance, in particular to antimetabolites and metal-based drugs, cancer pharmacogenomics and pharmacogenetics, and controlled clinical trials in gastrointestinal cancers

  • Kazuo Umezawa

    Aichi Medical University, JAPAN

    Interests: CPR, resuscitation, critical care medicine, intensive care medicine, hypothermia, emergency management, emergency treatment, sepsis, ventilation, ICU

Editorial Board Members
  • Jinhua Wang

    National Center for Pharmaceutical Screening, Institute of Materia Medica, CHINA

    Interests: the mechanism and drug targets of cancers

  • Makoto Kawatani

    RIKEN Center for Sustainable Resource Science (CSRS), JAPAN

    Interests: chemical biology, drug development and cancer research

  • Nocentini Giuseppe

    University of Perugia, ITALY

    Interests: pharmacology, immunotoxicology and pharmacoimmunology

  • Hiroyuki Osada

    RIKEN Center for Sustainable Resource Science (CSRS), JAPAN

    Interests: chemical biology research

  • Wunchana Seubwai

    Khon Kaen University, THAILAND

    Interests: cancer biology, cell signaling,cell culture, immunohistochemistry, apoptosis, cell proliferation, biochemistry, cancer cell biology, molecular cell biology, gene expression

  • Ryouichi Horie

    Kitasato University, JAPAN

    Interests: molecular hematology, medical sciences

  • David A. Gewirtz

    Virginia Commonwealth University, USA

    Interests: autophagy, cell biology, programmed cell death, apoptosis and senescence

  • Aamir Ahmad

    University of Alabama at Birmingham, USA

    Interests: cancer metastasis, drug resistance, miRNA and cancer health disparity

  • Isao Momose

    Institute of Microbial Chemistry, JAPAN

    Interests: bioorganic chemistry; applied biochemistry and applied microbiology

  • Yohko Yamazaki

    Institute of Microbial Chemistry, JAPAN

    Interests: androgen receptors, prostate cancer, anticancer drugs and phospholipid remodeling

  • Luca Maria Munaron

    University of Torino, ITALY

    Interests: tumor-derivedendothelial cells, drugdelivering against tumor vascularization and Bone vascularization and biomaterials

  • Petar Ozretić

    Laboratory for Hereditary Cancer, Ruđer Bošković Institute (RBI), CROATIA

    Interests: cancer genetics, epigenetics, bioinformatics, biostatistics and molecular oncology

  • Sanjay Gupta

    Case Western Reserve University, USA

    Interests: cancer biomarkers, cancer therapeutics and drug repurposing and cancer stem cells research

  • Hong Shen

    Xiangya Hospital, Central South University, CHINA

    Interests: tumor microenvironment, immunotherapy, tumor metabolism, epigenetic therapy, single-cell sequencing, cell proliferation, tumor metastasis

  • Jianxun Jim Song

    Texas A&M University Health Science Center, USA

    Interests: T cell biology, immunotherapy, stem cells, cancer, autoimmunity, cell metabolism, signal transduction

  • Ning Wei

    Montefiore Einstein Cancer Center, USA

    Interests: cancer pharmacology and drug discovery

  • Tao Liu

    Lowy Cancer Research Centre, AUSTRALIA

    Interests: oncology and carcinogenesis, cancer cell biology, cancer genetics, cancer therapy

  • Jinhui Liu

    The First Affiliated Hospital of Nanjing Medical University, CHINA

    Interests: biomarker, prognostic model, non-coding RNA, machine learning, bioinformatics, immunology

  • Mohammad Oves

    King Abdulaziz University, SAUDI ARABIA

    Interests: multidrug resistance, antimicrobial agents and nanomaterials bio-fabrication, biofilm, chromium reduction and phosphate solubilization microbe

  • Mohammad Rahimi-Gorji

    Ghent University, BELGIUM

    Interests: cancer and tumor modeling, drug delivery, intraperitoneal chemotherapy, CFD simulation of drug delivery, biomedical modeling 

  • Xu Dong Zhang

    University of Newcastle, AUSTRALIA

    Interests: melanoma, pancreatic, colorectal & rare cancers

  • Chunlin Ou

    Xiangya Hospital, Central South University, CHINA

    Interests: the regulatory mechanism of non-coding RNAs in cancers, clinical application of mRNA vaccine in cancers.

  • Yingying Lin

    Shanghai Jiaotong University, CHINA

    Interests: tumor microenvironment, protease, glioma

  • Stefania Nobili

    University of Florence, ITALY

    Interests: pharmacology, applied pharmacology

  • Hardeep Singh Tuli

    Maharishi Markandeshwar University, INDIA

    Interests: cordyceps, nanoparticles, cancer biology, microbial biotechnology, cell cycle, therapeutics

  • Ciro Isidoro

    Università del Piemonte Orientale, ITALY

    Interests: cancer biology, autophagy, cell death, cell biology, cancer research, apoptosis, cell proliferation

  • Antonio Ruggiero

    Fondazione Policlinico Universitario Gemelli IRCCS, ITALY

    Interests: pediatric clinical trials, clinical pharmacology of antineoplastic drugs, pain therapy and pediatric drugs

  • Francesca De Felice

    Sapienza University of Rome, ITALY

    Interests: gastrointestinal cancers, head and neck cancers, gynecological cancers, machine learning data analysis, survival analysis

  • William CHO

    Queen Elizabeth Hospital, HONG KONG

    Interests: molecular biology, proteomics, genomics, immunology, bioinformatics, next-generation sequencing

  • Ammad Ahmad Farooqi

    Institute of Biomedical and Genetic Engineering, PAKISTAN

    Interests: cancer genetics and therapeutics, targeting of oncogenic signaling pathways using natural products, restoration of apoptotic pathway in resistant cancers

  • Bahil Ghanim

    Karl Landsteiner University of Health Sciences, AUSTRIA

    Interests: biomarkers, thoracic surgery, lung cancer, mesothelioma, minimal invasive surgery and solitary fibrous tumor of the lung

  • Yong Teng

    Emory University School of Medicine, USA

    Interests: tumor microenvironment, tumor metabolism, and metastasis with an emphasis on molecular determinants

  • Marina Kriajevska

    University of Leicester, UK

    Interests: cell signaling, bladder cancer

  • Tao Li

    Qilu Hospital, Shandong University, CHINA

    Interests: the biology and treatment of Hepatobiliary tumors

  • Alfons Navarro Ponz

    University of Barcelona, SPAIN

    Interests: non-coding RNAs in solid and hematologic cancers, including colorectal cancer, non-small-cell lung cancer, Hodgkin lymphoma, acute myeloid leukemia, and multiple myeloma

  • Tianhui Chen

    Zhejiang Cancer Hospital, CHINA

    Interests: clinical epidemiology, molecular epidemiology, genetic epidemiology of familial cancer (colorectal cancer, breast cancer, ovarian cancer, pancreatic cancer)

  • Nobuyuki Horita

    Yokohama City University Hospital, JAPAN

    Interests: pulmonary disease, meta-analysis, propensity score matching, and survival analysis

  • Constantinos Mikelis

    University of Patras, GREECE

    Interests: investigating the role of the small GTPase RhoA on developmental and tumor-induced angiogenesis, lymphangiogenesis, on the role of endothelial RhoA on cancer cell trans-endothelial migration, signaling circuits, genetic alterations taking place in the endothelium upon incorporation of cancer-derived exosomes, as part of the pre-metastatic niche

  • Giovanni Monteleone

    University of Rome Tor Vergata, ITALY

    Interests: gastroenterology, cancer immunity and immunotherapy, liver and clinical research

  • Serge Weis

    Johannes Kepler University, AUSTRIA

    Interests: neurodegeneration,biological psychiatry, neuro-oncology, neuro-AIDS, temporal lobe epilepsy, neuromuscular, drug abuse and brain pathology, stroke and chlamydia, development of the human brain,sexual dimorphism, cerebral asymmetries, neuro-imaging and morphometry in micronanatomic neurosurgery, pituitary gland

  • Chin-Hsiao Tseng

    National Taiwan University Hospital, TAIWAN

    Interests: diabetes, arsenic-related health hazards, cancer issues related to diabetes and antidiabetic drugs

  • Roberto Passera

    University of Torino, AOU Città della Salute e della Scienza (Molinette Hospital), ITALY

    Interests: cancer clinical epidemiology and biostatistics, systematic reviews and meta-analyses in surgical oncology, chemo- and immunochemo- regimens in onco-hematology, new biomarkers for prostate cancer, pharmacokinetic and pharmacodynamic trials in oncology

  • Calvin Sze Hang Ng

    Chinese University of Hong Kong, HONG KONG

    Interests: lung cancer, tumor biology, metastasis, video-assisted thoracic surgey, clinical oncology

  • Shuyu Zhang

    Sichuan University, CHINA

    Interests: tumor radiosensitivity mechanisms and nuclear radiation damage prevention strategies

  • Manuel Graeber

    The University of Sydney, AUSTRALIA

    Interests: brain tumours, glioblastoma, microglia, brain macrophages, tumour microenvironment, neurogenetics

  • Alexander Shtil

    Blokhin Cancer Center, RUSSIA

    Interests: mechanisms of tumor cell death, drug resistance, antitumor drug design

  • Sebastiano Mercadante

    La Maddalena Cancer Center, ITALY

    Interests: cancer pain, palliative medicine, anesthesiology

  • George Gong CHEN

    The Chinese University of Hong Kong, HONG KONG

    Interests: head and neck cancers, especially thyroid cancer and laryngeal cancer

  • Sandra E. Ghayad

    Aix-Marseille Université, FRANCE

    Interests: cancer cells; cancer therapy; tumors thrombosis; senescence; exosomes; microvesicles

  • Cheorl-Ho Kim

    Sungkyunkwan University, KOREA

    Interests: innate immunity; microbe-host interasction; angiogensis; differentiation; invasion; ethnopharmcology; molecular and cellular glycobiology; cancer research

  • Wenxue Ma

    University of California, USA

    Interests: cancer stem cell (CSC), cancer immunotherapy, antigen presentation, tumor neoantigens, Cytotoxic T-Lymphocytes (CTLs), tumor-infiltrating lymphocytes (TILs), dug delivery with nanotechnology (Nanomedicine), targeted cancer therapy, circulating tumor cell (CTC), biomarkers

  • Luca Bertolaccini

    European Institute of Oncology IRCCS, ITALY

    Interests: lung cancer surgery, minimally invasive thoracic surgery, thoracic oncology, biostatistics

  • Leonardo Oliveira Reis

    Pontifical Catholic University of Campinas, BRAZIL

    Interests: prostate cancer; urologic surgical; bladder cancer; cancer diagnostics; urologic oncology; cryosurgery; translational research; evidence based medicine; hydronephrosis

  • Ying Liu

    Qingdao University, CHINA

    Interests: basic and applied research on nuclear receptor signal transduction, protein post-translational modification, identification of tumor biomarkers, and bioinformatics

  • Maria Caffo

    University of Messina, ITALY

    Interests: glioblastoma multiforme (GBM), astrocytoma, medulloblastoma, neuroradiology, magnetic resonance, glioma, molecular oncology, meningioma,neurosurgery

  • Hooman Yarmohammadi

    Memorial Sloan-Kettering Cancer Center, USA

    Interests: diagnostic radiology; diagnosis; pancreatic cancer; interventional radiology; endovascular procedures; tumors; lung; cancer biology; animal studies

  • Consolato Sergi

    University of Ottawa, CANADA

    Interests: biology and pathology of the cardiovascular, gastrointestinal System and gut, bile microbiome, bone cell biology, pediatric pathology with nanotech applications for oncology

  • Xiaofang Che

    The First Hospital of China Medical University, CHINA

    Interests: tumor microenvironment, hypoxia, immunology, cancer, proliferation, drug resistance, metastasis, exosome, non-cording RNA, m6A methylation, post-translational modification, biomarker

  • Jing He

    Guangzhou Women and Children's Medical Center, CHINA

    Interests: cancer genetics, cancer epidemiology, molecular epidemiology, cancer therapy, signal transduction, pediatric oncology, evidence-based medicine (meta-analysis), molecular biology

  • Pierlorenzo Pallante

    IEOS, Consiglio Nazionale delle Ricerche (CNR), ITALY

    Interests: non-coding RNA, cancer biology, biomarkers, cell biology, cancer therapy, prognosis, pharmacology, cancer chemotherapy, translational research in the field of lung and colorectal oncology

  • Hasan Mahmud Reza

    North South University, BANGLADESH

    Interests: pharmaceutical dosage form development, pharmacological studies with natural products and available molecules using animal disease models, molecular biology and biochemistry, cell culture

Early Career Editorial Board Member
  • Romeo Patini

    Catholic university of Sacred Heart Rome, ITALY

    Interests: molecular biology, biological fluids proteomics

  • Chavda Vivek Prakash Bhai

    L.M. College of Pharmacy, INDIA

    Interests: complex injectable, biologics, immunotherapy and vaccine

  • Emanuele Perrone

    Fondazione Policlinico Agostino Gemelli IRCCS, ITALY

    Interests: gynecology oncology, cervical, ovarian and endometrial cancer

  • Hao Zhang

    Chongqing Medical University, CHINA

    Interests: tumor microenvironment; cancer immunotherapy; small molecule drug; molecular mechanism; bioinformatics; target therapy; signal transduction

  • Jiyoon Bu

    INHA University, KOREA

    Interests: drug delivery, nano engineering, liquid biopsy, immunotherapy

  • Marzia Di Donato

    University of Campania “L.Vanvitelli”, ITALY

    Interests: androgens/androgen receptor axis, steroids; growth factors, receptors, signal transduction, cell cycle, invasiveness, breast and prostate cancer, tumor microenvironment, cell differentiation, cell biology, migration, cell proliferation

  • Yaying Sun

    Huashan Hospital, CHINA

    Interests: multi-organic crosstalk in terms of musculoskeletal and immune system, development of novel nanomedicine delivery system, prognostic factors and predictive model establishment of different cancers

  • Fernando Mendes

    Instituto Politécnico de Coimbra, PORTUGAL

    Interests: lung cancer, lymphoma, blood bank, immunhematology, cancer treatement, radiotherapy, immune system, forsman blood group

  • Gerardo Cazzato

    University of Bari "Aldo Moro", ITALY

    Interests: lung diseases; mediastinal diseases; mesothelioma; skin; thoracic diseases; melanoma; dermatopathology; clinical dermatology; squamous cell carcinoma

  • Ziheng Wang

    Nantong University, CHINA

    Interests: bioinformatics analysis; clinical problems with machine learning; oncology using single-cell omics strategies; basic and clinical research studies; molecular pathology; etiology and pathogenesis; biomarkers; genomics; transcriptome; proteomics; metabonomics; prognosis

  • Roberto Cuomo

    University of Siena, ITALY

    Interests: melanoma, squamous cell carcinoma, basal cell carcinoma, skin cancer, rare skin cancer, breast cancer

  • Le Su

    Jacksonville State University, USA

    Interests: epigenetics, childhood cancer (molecular and cellular basis of childhood sarcomas), targeted therapy

Editorial Advisory Board
  • L. J. Appleman

    University of Pittsburgh, USA

    Interests: tumor immunology, clinical trial of an autologous dendritic cell vaccine, cancer immunotherapy

  • N. Bahary

    University of Pittsburgh, USA

    Interests: oncologists diagnose, cancer surgeons, or surgical oncologists, remove tumors, while medical oncologists treat cancers with chemotherapy, gastrointestinal cancer

  • J. R. Bertino

    Rutgers Cancer Institute of New Jersey, USA

    Interests: cancer biology, lymphomas, antimetabolites

  • J. H. Beumer

    Hillman Cancer Center, USA

    Interests: pharmacology, toxicology

  • M. Boyiadzis

    University of Pittsburgh, USA

    Interests: internal medicine, hematology/oncology, medical oncology

  • Y.-C. Cheng

    Yale University School of Medicine, USA

    Interests: pharmacology, antiviral drugs against HBV, HIV, EBV, and HCV, as well as the discovery of antivirals with unique mode of action against those viruses.

  • M. S. Copur

    University of Nebraska, USA

    Interests: medical oncology, hematology

  • A. Krishnamurthy

    University of Pittsburgh, USA

    Interests: diagnosis and multidisciplinary management of gastrointestinal (GI) cancers

  • Y. Li

    Sorrento Therapeutics, USA

    Interests: tumor immunology, molecular biology, medical genetics and clinical medicine

  • M. Rudek

    Johns Hopkins University, USA

    Interests: clinical pharmacology of anticancer agents; early phase drug development; drug tolerability in cancer patients with HIV/AIDS; drug tolerability in cancer patients with organ dysfunction; blood-brain barrier penetration of drugs.

  • J. C. Schmitz

    University of Pittsburgh, USA

    Interests: pharmacodynamic, the mechanism(s) of action of quassinoids on colorectal cancer cells and tumors

  • L. Zhang

    University of Pittsburgh, USA

    Interests: pharmacology and chemical Biology

  • A. H. Calvert

    University of Newcastle upon Tyne, UK

    Interests: tumor biology

  • A. Di Paolo

    University of Pisa, ITALY

    Interests: pharmacology, clinical pharmacokinetics and PK/PD of antineoplastic and antiinfective drugs

  • D. Longley

    Queen’s University, UK

    Interests: apoptosis proteins, birinapant, poptosis

  • J. Robert

    Université de Bordeaux, FRANCE

    Interests: pharmacocinétique, métabolisme et résistance, pharmacologie cellulaire et moléculaire, pharmacogénétique

  • J. H. M. Schellens

    Netherlands Cancer Institute, the Netherlands

    Interests: clinical pharmacology

  • P. Workman

    CRC Center for Cancer Therapeutics, UK

    Interests: drug discovery, molecular pharmacology and chemical biology approaches

  • A. Deguchi

    Tokyo Women’s Medical University, JAPAN

    Interests: pharmacology, cancer research

  • X. Ding

    Nanjing Medical University, CHINA

    Interests: digestive diseases

  • S. Gantsev

    Bashkirian State Medical University, RUSSIAN

    Interests: pharmacology

  • Y. Horiguchi

    Tokyo Medical University, JAPAN

    Interests: biomaterials and bioengineering

  • M. Imoto

    Keio University, JAPAN

    Interests: nanotechnology, materials, chemical biology

  • H. Kakeya

    Kyoto University, JAPAN

    Interests: chemical biology

  • M. Kawatani


    Interests: interdisciplinary science & engineering, biological sciences

  • E. Kikuchi

    Keio University, JAPAN

    Interests: neuropsychiatry

  • K. P. Kim

    University of Ulsan College of Medicine, KOREA

    Interests: pre-medicine, clinical pharmacology

  • T. W. Kim

    University of Ulsan College of Medicine, KOREA

    Interests: medicine

  • Y. Lin

    Aichi Medical University, JAPAN

    Interests: pancreatic cancer, gastric cancer, epidemiologic studies, esophageal cancer

  • J. Neuzil

    Griffith University, Gold Coast Campus, AUSTRALIA

    Interests: medical microbiology, oncology and carcinogenesis

  • O. Ohno

    Kogakuin University, JAPAN

    Interests: immunology

  • T. Ohsugi

    Rakuno Gakuen University, JAPAN

    Interests: genetically modified mice, MNVmouse norovirusspecific pathogen-freemicrobiological monitoring HTLV-1 animal modeltaxTransgenic miceATLL

  • M. Oya

    Keio University, JAPAN

    Interests: urology

  • M. Ozaki

    Hokkaido University, JAPAN

    Interests: biomedical imaging, oxidative stress, non-alcoholic fatty liver disease

  • Y. Sasazawa

    Juntendo University, JAPAN

    Interests: proteomics and biomolecular science

  • K. Sidthipong

    Mahidol University, THAILAND

    Interests: biology, chemistry, bioorganic & medicinal chemistry letters

  • S. Simizu

    Keio University, JAPAN

    Interests: cancer, molecular target therapy, inflammation, chemical biology

  • M. Takeiri

    Ivy Cosmetics, JAPAN

    Interests: osteoclasts

  • E. Tashiro

    Showa Pharmaceutical University, JAPAN

    Interests: nature chemical biology

  • T. Ueno

    Tsukuba University, JAPAN

    Interests: materials science

  • M. Yamamoto

    Waseda University, JAPAN

    Interests: infrared, FTIR analysis, infrared spectrophotom

Share Link